Notably, CXCR4 is the most extensively studied chemokine receptor in malignant hematologic diseases, being closely associated with malignant proliferation, apoptosis regulation, chemotherapy resistance, and the bone marrow microenvironment of leukemia cells [96]. Here, CXCR4 is linked to hematologic disorder.